Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Geographic Atrophy in AMD
NCT01675947Phase 2Terminated
- Sponsor
- National Eye Institute
- Start
- Feb 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in geographic atrophy (GA), sponsored by National Eye Institute. Started Feb 2012; status: terminated.
02
Drugs
sirolimus
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01675947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675947.